These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 16423996

  • 1. c-myc overexpression causes anaplasia in medulloblastoma.
    Stearns D, Chaudhry A, Abel TW, Burger PC, Dang CV, Eberhart CG.
    Cancer Res; 2006 Jan 15; 66(2):673-81. PubMed ID: 16423996
    [Abstract] [Full Text] [Related]

  • 2. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
    von Hoff K, Hartmann W, von Bueren AO, Gerber NU, Grotzer MA, Pietsch T, Rutkowski S.
    Pediatr Blood Cancer; 2010 Mar 15; 54(3):369-76. PubMed ID: 19908297
    [Abstract] [Full Text] [Related]

  • 3. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
    von Bueren AO, Shalaby T, Rajtarova J, Stearns D, Eberhart CG, Helson L, Arcaro A, Grotzer MA.
    BMC Cancer; 2007 Jan 25; 7():19. PubMed ID: 17254356
    [Abstract] [Full Text] [Related]

  • 4. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
    Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD.
    Cancer Res; 1990 Apr 15; 50(8):2347-50. PubMed ID: 2180567
    [Abstract] [Full Text] [Related]

  • 5. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.
    Sanchez-Diaz PC, Burton TL, Burns SC, Hung JY, Penalva LO.
    BMC Cancer; 2008 Sep 30; 8():280. PubMed ID: 18826648
    [Abstract] [Full Text] [Related]

  • 6. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
    Eberhart CG, Kratz J, Wang Y, Summers K, Stearns D, Cohen K, Dang CV, Burger PC.
    J Neuropathol Exp Neurol; 2004 May 30; 63(5):441-9. PubMed ID: 15198123
    [Abstract] [Full Text] [Related]

  • 7. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
    Takei H, Nguyen Y, Mehta V, Chintagumpala M, Dauser RC, Adesina AM.
    J Neurosurg Pediatr; 2009 Jan 30; 3(1):61-5. PubMed ID: 19119907
    [Abstract] [Full Text] [Related]

  • 8. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
    Huang A, Ho CS, Ponzielli R, Barsyte-Lovejoy D, Bouffet E, Picard D, Hawkins CE, Penn LZ.
    Cancer Res; 2005 Jul 01; 65(13):5607-19. PubMed ID: 15994933
    [Abstract] [Full Text] [Related]

  • 9. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.
    Zhou L, Picard D, Ra YS, Li M, Northcott PA, Hu Y, Stearns D, Hawkins C, Taylor MD, Rutka J, Der SD, Huang A.
    Cancer Res; 2010 Oct 15; 70(20):8199-210. PubMed ID: 20876797
    [Abstract] [Full Text] [Related]

  • 10. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
    Raetz EA, Kim MK, Moos P, Carlson M, Bruggers C, Hooper DK, Foot L, Liu T, Seeger R, Carroll WL.
    Cancer; 2003 Aug 15; 98(4):841-53. PubMed ID: 12910530
    [Abstract] [Full Text] [Related]

  • 11. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
    Pietsch T, Scharmann T, Fonatsch C, Schmidt D, Ockler R, Freihoff D, Albrecht S, Wiestler OD, Zeltzer P, Riehm H.
    Cancer Res; 1994 Jun 15; 54(12):3278-87. PubMed ID: 8205550
    [Abstract] [Full Text] [Related]

  • 12. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
    Grotzer MA, von Hoff K, von Bueren AO, Shalaby T, Hartmann W, Warmuth-Metz M, Emser A, Kortmann RD, Kuehl J, Pietsch T, Rutkowski S.
    Klin Padiatr; 2007 Jun 15; 219(6):312-7. PubMed ID: 18050040
    [Abstract] [Full Text] [Related]

  • 13. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth.
    Hatton BA, Knoepfler PS, Kenney AM, Rowitch DH, de Alborán IM, Olson JM, Eisenman RN.
    Cancer Res; 2006 Sep 01; 66(17):8655-61. PubMed ID: 16951180
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice.
    McCall TD, Pedone CA, Fults DW.
    Cancer Res; 2007 Jun 01; 67(11):5179-85. PubMed ID: 17545597
    [Abstract] [Full Text] [Related]

  • 15. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior.
    Min HS, Lee YJ, Park K, Cho BK, Park SH.
    Acta Neuropathol; 2006 Jul 01; 112(1):13-20. PubMed ID: 16691420
    [Abstract] [Full Text] [Related]

  • 16. Establishment and characterization of four human medulloblastoma-derived cell lines.
    Keles GE, Berger MS, Srinivasan J, Kolstoe DD, Bobola MS, Silber JR.
    Oncol Res; 1995 Jul 01; 7(10-11):493-503. PubMed ID: 8866661
    [Abstract] [Full Text] [Related]

  • 17. [Risk stratification in medulloblastoma: screening for molecular markers].
    Ebinger M, Senf L, Scheurlen W.
    Klin Padiatr; 2006 Jul 01; 218(3):139-42. PubMed ID: 16688669
    [Abstract] [Full Text] [Related]

  • 18. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
    Rutkowski S, von Bueren A, von Hoff K, Hartmann W, Shalaby T, Deinlein F, Warmuth-Metz M, Soerensen N, Emser A, Bode U, Mittler U, Urban C, Benesch M, Kortmann RD, Schlegel PG, Kuehl J, Pietsch T, Grotzer M.
    Clin Cancer Res; 2007 May 01; 13(9):2651-7. PubMed ID: 17473196
    [Abstract] [Full Text] [Related]

  • 19. Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts.
    Philipova T, Baryawno N, Hartmann W, Pietsch T, Druid H, Johnsen JI, Ekström TJ.
    Int J Oncol; 2011 Mar 01; 38(3):843-9. PubMed ID: 21184030
    [Abstract] [Full Text] [Related]

  • 20. c-Myc promoter activation in medulloblastoma.
    Siu IM, Lal A, Blankenship JR, Aldosari N, Riggins GJ.
    Cancer Res; 2003 Aug 15; 63(16):4773-6. PubMed ID: 12941792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.